Datta Pallab, Ayan Bugra, Ozbolat Ibrahim T
Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology Shibpur, Howrah 711103, West Bengal, India.
Engineering Science and Mechanics Department, Penn State University, University Park, PA 16802, USA; The Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, USA.
Acta Biomater. 2017 Mar 15;51:1-20. doi: 10.1016/j.actbio.2017.01.035. Epub 2017 Jan 11.
Bioprinting is a promising technology to fabricate design-specific tissue constructs due to its ability to create complex, heterocellular structures with anatomical precision. Bioprinting enables the deposition of various biologics including growth factors, cells, genes, neo-tissues and extra-cellular matrix-like hydrogels. Benefits of bioprinting have started to make a mark in the fields of tissue engineering, regenerative medicine and pharmaceutics. Specifically, in the field of tissue engineering, the creation of vascularized tissue constructs has remained a principal challenge till date. However, given the myriad advantages over other biofabrication methods, it becomes organic to expect that bioprinting can provide a viable solution for the vascularization problem, and facilitate the clinical translation of tissue engineered constructs. This article provides a comprehensive account of bioprinting of vascular and vascularized tissue constructs. The review is structured as introducing the scope of bioprinting in tissue engineering applications, key vascular anatomical features and then a thorough coverage of 3D bioprinting using extrusion-, droplet- and laser-based bioprinting for fabrication of vascular tissue constructs. The review then provides the reader with the use of bioprinting for obtaining thick vascularized tissues using sacrificial bioink materials. Current challenges are discussed, a comparative evaluation of different bioprinting modalities is presented and future prospects are provided to the reader.
Biofabrication of living tissues and organs at the clinically-relevant volumes vitally depends on the integration of vascular network. Despite the great progress in traditional biofabrication approaches, building perfusable hierarchical vascular network is a major challenge. Bioprinting is an emerging technology to fabricate design-specific tissue constructs due to its ability to create complex, heterocellular structures with anatomical precision, which holds a great promise in fabrication of vascular or vascularized tissues for transplantation use. Although a great progress has recently been made on building perfusable tissues and branched vascular network, a comprehensive review on the state-of-the-art in vascular and vascularized tissue bioprinting has not reported so far. This contribution is thus significant because it discusses the use of three major bioprinting modalities in vascular tissue biofabrication for the first time in the literature and compares their strengths and limitations in details. Moreover, the use of scaffold-based and scaffold-free bioprinting is expounded within the domain of vascular tissue fabrication.
生物打印是一种很有前景的技术,可用于制造特定设计的组织构建体,因为它能够精确地创建复杂的异细胞结构。生物打印能够沉积各种生物制剂,包括生长因子、细胞、基因、新组织和细胞外基质样水凝胶。生物打印的优势已开始在组织工程、再生医学和制药领域崭露头角。具体而言,在组织工程领域,构建血管化组织构建体至今仍是一项主要挑战。然而,鉴于其相对于其他生物制造方法具有众多优势,人们自然而然地期望生物打印能够为血管化问题提供可行的解决方案,并促进组织工程构建体的临床转化。本文全面介绍了血管和血管化组织构建体的生物打印。综述的结构为:先介绍生物打印在组织工程应用中的范围、关键血管解剖特征,然后详细介绍使用基于挤出、液滴和激光的生物打印技术进行三维生物打印以制造血管组织构建体。综述接着向读者介绍了使用牺牲性生物墨水材料通过生物打印获得厚血管化组织的方法。讨论了当前面临的挑战,对不同生物打印方式进行了比较评估,并向读者展望了未来前景。
在临床相关体积下对活组织和器官进行生物制造至关重要地依赖于血管网络的整合。尽管传统生物制造方法取得了巨大进展,但构建可灌注的分级血管网络仍是一项重大挑战。生物打印是一种新兴技术,可用于制造特定设计的组织构建体,因为它能够精确地创建复杂的异细胞结构,这在制造用于移植的血管或血管化组织方面具有巨大潜力。尽管最近在构建可灌注组织和分支血管网络方面取得了很大进展,但迄今为止尚未有关于血管和血管化组织生物打印最新进展的全面综述报道。因此,本论文具有重要意义,因为它首次在文献中讨论了三种主要生物打印方式在血管组织生物制造中的应用,并详细比较了它们的优缺点。此外,还阐述了在血管组织制造领域中基于支架和无支架生物打印的应用。